SunText Review of Endocrine Care

ISSN: 2771-5469

Article Type : Case Report

Clinical Perspectives of Luseogliflozin and Vildagliptin/Metformin (EquMet) in Patients with Type 2 Diabetes (T2D) and Renal Stone

Authors : Bando M, Hayami E, Abe H, Little M, Taiji M, Nishitani N and Bando H

DOI : 10.51737/2771-5469.2023.012
PDF Full Text DOI

Article Type : Short commentary

Rapid Decrease of HbA1c by Imeglimin (Twymeeg) in Patient with Obesity and Type 2 Diabetes (T2D)

Authors : Bando H, Kato Y, Yamashita H, Kato Y and Ogura K

DOI : 10.51737/2771-5469.2023.011
PDF Full Text DOI

Article Type : Short commentary

Improved Glucose Variability by Imeglimin (Twymeeg) After Hypoglycemic Episode in T2D Patient

Authors : Bando H, Ogawa H, Kobayashi H, Nagahiro S, Nakanishi S and Watanabe O

DOI : 10.51737/2771-5469.2023.009
PDF Full Text DOI

Article Type : Short commentary

Improvement of Obesity and Type 2 Diabetes (T2D) by Oral Semaglutide (Rybelsus) and Super-Low Carbohydrate Diet (LCD)

Authors : Bando H, Iwatsuki N, Okada M, Ogawa T and Sakamoto K

DOI : 10.51737/2771-5469.2023.010
PDF Full Text DOI

Article Type : Short commentary

Effective Treatment for Type 2 Diabetes (T2D) by Imeglimin (Twymeeg) and Vildagliptin/Metformin (EquMet)

Authors : Bando H, Kato Y, Yamashita H, Kato Y and Kawata T

DOI : 10.51737/2771-5469.2023.008
PDF Full Text DOI